• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《环状RNA circSnx12通过miR-194-5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性》的勘误

Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.

作者信息

Qin Kaiyun, Zhang Fenghua, Wang Hongxia, Wang Na, Qiu Hongbing, Jia Xinzhuan, Gong Shan, Zhang Zhengmao

机构信息

Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011; Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, China.

Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, China.

出版信息

BMB Rep. 2023 Jul;56(7):416.

PMID:37500559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390286/
Abstract

[Erratum to: BMB Reports 2023; 56(3): 184-189, PMID: 36617466, PMCID: PMC10068343] The BMB Reports would like to correct in BMB Rep. 56(3): 184-189, titled "circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis". This research has the wrong affiliation of the authors and number of affiliation. Since author's affiliation is incorrect, this information has now been corrected as follows. Kaiyun Qin, Fenghua Zhang, Hongxia Wang, Na Wang, Hongbing Qiu, Xinzhuan Jia, Shan Gong & Zhengmao Zhang Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, Department of Gynecology, Hebei Xingtai People's Hospital, Hebei Shijiazhuang 054001, Department of Reproductive Medicine, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, China The author apologizes for any inconvenience or confusion this error may cause. Author information has been modified in the original PDF version.

摘要

[《BMB报告》勘误:2023年;56(3): 184 - 189,PMID: 36617466,PMCID: PMC10068343]《BMB报告》希望对发表于《BMB报告》56(3): 184 - 189,标题为“环状RNA circSnx12通过miR - 194 - 5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性”的文章进行勘误。本研究作者的单位信息及单位数量有误。由于作者单位信息错误,现更正如下。秦凯云、张凤华、王红霞、王娜、邱红兵、贾新转、龚珊、张正茂 河北医科大学第四医院妇科,河北石家庄050011;河北省人民医院乳腺甲状腺外科,河北石家庄050057;河北省人民医院妇科,河北石家庄050057;河北省邢台市人民医院妇科,河北石家庄054001;河北医科大学第四医院生殖医学科,河北石家庄050011,中国 作者对该错误可能造成的任何不便或混淆表示歉意。作者信息已在原始PDF版本中修改。

相似文献

1
Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.《环状RNA circSnx12通过miR-194-5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性》的勘误
BMB Rep. 2023 Jul;56(7):416.
2
Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.《环状RNA circSnx12通过miR-194-5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性》的勘误
BMB Rep. 2024 Feb;57(2):122.
3
circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.环状 RNA circSnx12 通过 miR-194-5p/SLC7A11 轴抑制铁死亡从而赋予卵巢癌细胞顺铂耐药性。
BMB Rep. 2023 Mar;56(2):184-189. doi: 10.5483/BMBRep.2022-0175.
4
Erratum to: Stomach clusterin as a gut-derived feeding regulator.《胃聚集素作为一种源自肠道的进食调节因子》的勘误
BMB Rep. 2024 Jul;57(7):342.
5
Erratum to: Exercise-induced beige adipogenesis of iWAT in Cidea reporter mice.《Cidea报告基因小鼠中白色脂肪组织运动诱导的米色脂肪生成》勘误
BMB Rep. 2022 Jul;55(7):360.
6
Erratum to: Human umbilical cord mesenchymal stem cell-derived mitochondria (PN-101) attenuate LPS-induced inflammatory responses by inhibiting NFκB signaling pathway.勘误:人脐带间充质干细胞来源的线粒体(PN - 101)通过抑制NFκB信号通路减轻脂多糖诱导的炎症反应。
BMB Rep. 2022 Jul;55(7):361.
7
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.撤稿声明:丁,J.,王,X.,高,J. 和宋,T.(2021年),胱抑素SN沉默可消除甲状腺乳头状癌的癌症进展和干细胞特性。《欧洲生物化学学会联合会开放生物学》,11: 2186 - 2197。
FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
8
Corrigendum on: Wang H, Chen C, Li J, Yang X, Zhang H and Wang Z. Modified first dorsal metacarpal artery island flap for sensory reconstruction of thumb pulp defects. J Hand Surg Eur. 2016, 41: 177-84.关于以下文献的勘误:王H、陈C、李J、杨X、张H和王Z。改良第一掌背动脉岛状皮瓣用于拇指指腹缺损的感觉重建。《欧洲手外科杂志》。2016年,41卷:177 - 184页。
J Hand Surg Eur Vol. 2016 May;41(4):462. doi: 10.1177/1753193416634262. Epub 2016 Mar 2.
9
Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer.利多卡因通过靶向miR-382-5p/SLC7A11轴促进卵巢癌和乳腺癌的铁死亡。
Front Pharmacol. 2021 May 26;12:681223. doi: 10.3389/fphar.2021.681223. eCollection 2021.
10
Erratum to: Regulation of post-translational modification in breast cancer treatment.《乳腺癌治疗中翻译后修饰的调控》勘误
BMB Rep. 2019 Dec;52(12):728.